The National Medicines and Food Health Institute (OGYÉI) has granted a licence for the Chinese Sinopharm coronavirus vaccine to be used in Hungary, the chief medical officer said on Friday.
Cecília Müller noted that Sinopharm will be available in addition to the Pfizer, Moderna, Sputnik V, and AstraZeneca vaccines already licenced in Hungary. Müller said hopefully the vaccines would be available in large quantities and the Hungarian population could be vaccinated “in a shorter period”. Hungary’s health authorities will rely on the cooperation of family doctors to inoculate seniors, she added.
MTI
Photo: MTI/AP/Darko Vojinovic
